Nasal and Cutaneous Carriage of Staphylococcus aureus in Hemodialysis Patients: The Effect of Nasal Mupirocin
Infection Control and Hospital Epidemiology1996Vol. 17(12), pp. 809–811
Citations Over TimeTop 12% of 1996 papers
Abstract
Fifteen of 20 hemodialysis patients who carried Staphylococcus aureus in their nares also carried the organism on their hands; 2 of 20 patients who did not carry S aureus in their nares carried S aureus on their hands (P < .001). Eighty-seven percent of patients who carried S aureus in their nares and on their hands carried the same strain at both sites. Intranasal mupirocin eliminated S aureus from both sites.
Related Papers
- → Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA(2015)185 cited
- → Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects(2009)179 cited
- → Prevention of Surgical Site Infections: Decontamination With Mupirocin Based on Preoperative Screening forStaphylococcus aureusCarriers or Universal Decontamination?(2015)58 cited
- → Mupirocin susceptibility of staphylococci 2022: Is it time for a change in MRSA decolonization protocols?(2022)15 cited
- → New approaches to prevention of staphylococcal infection in surgery(2008)27 cited